Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 136, Issue 1, 2013, Pages 258-263

  Singh, Prashant K ^a   Doig, Craig L ^b   Dhiman, Vineet K ^a   Turner, Bryan M ^b   Smiraglia, Dominic J ^a   Campbell, Moray J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Epigenetics; NCOR1; Prostate cancer; VDR

Indexed keywords

MESSENGER RNA; VITAMIN D RECEPTOR;

ACETYLATION; ATTENUATION; BINDING SITE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; COMPARATIVE STUDY; DNA METHYLATION; EPIGENETICS; GENE REGULATORY NETWORK; GENE TARGETING; PROSTATE CANCER; PROSTATE EPITHELIUM; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSCRIPTION REGULATION;

EID: 84881184830     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.10.002     Document Type: Review

References (88)

1. D.B. Lubahn, et al., Cloning of human androgen receptor complementary DNA and localization to the X chromosome, Science 240 (4850) (1988) 327-330.
2. J.F. Kerr, A.H. Wyllie, A.R. Currie, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, British Journal of Cancer 26 (4) (1972) 239-257.
3. H. Li, et al., Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways, Journal of Biological Chemistry 279 (6) (2004) 4212-4220.
4. X. Yang, et al., Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells, Oncogene 25 (24) (2006) 3436-3444.
5. M.J. Campbell, et al., Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin, Journal of Molecular Endocrinology 19 (1) (1997) 15-27.
6. F.L. Khanim, et al., Altered SMRT levels disrupt vitamin D(3) receptor signalling in prostate cancer cells, Oncogene 23 (40) (2004) 6712-6725.
7. T. Kubota, et al., 19-Nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells, Cancer Research 58 (15) (1998) 3370-3375.
8. M. Liu, et al., Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937, Genes and Development 10 (2) (1996) 142-153.
9. A. Saramaki, et al., Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor, Nucleic Acids Research 34 (2) (2006) 543-554.
10. J. Thorne, M.J. Campbell, The vitamin D receptor in cancer, Proceedings of the Nutrition Society 67 (2) (2008) 115-127.
11. H.G. Palmer, et al., Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling, Journal of Cell Biology 154 (2) (2001) 369-387.
12. S. Kitareewan, et al., G0S2 is an all-trans-retinoic acid target gene, International Journal of Oncology 33 (2) (2008) 397-404.
13. F. Zandbergen, et al., The G0/G1 switch gene 2 is a novel PPAR target gene, Biochemical Journal 392 (Pt. 2) (2005) 313-324.
14. P.J. Hendriksen, et al., Evolution of the androgen receptor pathway during progression of prostate cancer, Cancer Research 66 (10) (2006) 5012-5020.
15. S.S. Taneja, et al., ART-27, an androgen receptor coactivator regulated in prostate development and cancer, Journal of Biological Chemistry 279 (14) (2004) 13944-13952.
16. S.A. Tomlins, et al., Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Science 310 (5748) (2005) 644-648.
17. S.P. Anderson, et al., Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor {alpha}, retinoid × receptor and liver × receptor in mouse liver, Molecular Pharmacology 66 (6) (2004) 1440-1452.
18. A.L. Bookout, et al., Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network, Cell 126 (4) (2006) 789-799.
19. C. Handschin, U.A. Meyer, Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR, Archives of Biochemistry and Biophysics 433 (2) (2005) 387-396.
20. Q. Wang, et al., Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer, Cell 138 (2) (2009) 245-256.
21. F.L. Khanim, et al., Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells, Oncogene 23 (40) (2004) 6712-6725.
22. S.F. Rashid, et al., Synergistic growth inhibition of prostate cancer cells by 1 alpha, 25 dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A, Oncogene 20 (15) (2001) 1860-1872.
23. R.J. Lin, et al., Role of the histone deacetylase complex in acute promyelocytic leukaemia, Nature 391 (6669) (1998) 811-814.
24. C.M. Banwell, et al., Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells, Clinical Cancer Research 12 (7 Pt. 1) (2006) 2004-2013.
25. H.J. Ting, et al., Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha, 25-dihydroxyvitamin D3 responsiveness, Molecular Cancer Research 5 (9) (2007) 967-980.
26. S.A. Abedin, et al., Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells, Carcinogenesis 30 (3) (2009) 449-456.
27. S. Battaglia, O. Maguire, M.J. Campbell, Transcription factor co-repressors in cancer biology: roles and targeting, International Journal of Cancer 126 (11) (2010) 2511-2519.
28. J.D. Chen, K. Umesono, R.M. Evans, SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers, Proceedings of the National Academy of Sciences of the United States of America 93 (15) (1996) 7567-7571.
29. B.J. Mengeling, et al., SMRTepsilon, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors alpha and beta, Molecular and Cellular Endocrinology 351 (2) (2012) 306-316.
30. M.L. Goodson, B.A. Jonas, M.L. Privalsky, Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors, Journal of Biological Chemistry 280 (9) (2005) 7493-7503.
31. J.L. Thorne, et al., Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells, Nucleic Acids Research 39 (6) (2011) 2045-2056.
32. S. Battaglia, et al., Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion, Carcinogenesis 31 (9) (2010) 1650-1660.
33. D.M. Altintas, et al., Cell cycle regulated expression of NCoR might control cyclic expression of androgen responsive genes in an immortalized prostate cell line, Molecular and Cellular Endocrinology 332 (1-2) (2011) 149-162.
34. A.J. Horlein, et al., Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor, Nature 377 (6548) (1995) 397-404.
35. J.D. Chen, R.M. Evans, A transcriptional co-repressor that interacts with nuclear hormone receptors, Nature 377 (6548) (1995) 454-457.
36. J. Li, et al., Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3, EMBO Journal 19 (16) (2000) 4342-4350.
37. V. Perissi, et al., Deconstructing repression: evolving models of co-repressor action, Nature Reviews Genetics 11 (2) (2010) 109-123.
38. K. Jepsen, et al., Cooperative regulation in development by SMRT and FOXP1, Genes and Development 22 (6) (2008) 740-745.
39. C. Yu, et al., The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis, Journal of Biological Chemistry 280 (14) (2005) 13600-13605.
40. J. Tiefenbach, et al., SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription, Molecular Biology of the Cell 17 (4) (2006) 1643-1651.
41. M. Surjit, et al., Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor, Cell 145 (2) (2011) 224-241.
42. S. Heikkinen, et al., Nuclear hormone 1alpha, 25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy, Nucleic Acids Research 39 (21) (2011) 9181-9193.
43. S.K. Raghav, et al., Integrative genomics identifies the corepressor SMRT as a gatekeeper of adipogenesis through the transcription factors C/EBPbeta and KAISO, Molecular Cell 46 (3) (2012) 335-350.
44. G.D. Barish, et al., The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis, Cell Metabolism 15 (4) (2012) 554-562.
45. C. Muller-Tidow, et al., Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia, Blood 116 (18) (2010) 3564-3571.
46. C. Hoemme, et al., Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip, Blood 111 (5) (2008) 2887-2895.
47. I. Girault, et al., Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen, Clinical Cancer Research 9 (4) (2003) 1259-1266.
48. J.Y. Kim, Y.L. Son, Y.C. Lee, Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor, Molecular Endocrinology 23 (2) (2009) 251-264.
49. T.H. Chang, E. Szabo, Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung, Clinical Cancer Research 8 (4) (2002) 1206-1212.
50. S. Ghisletti, et al., Cooperative NCoR/SMRT interactions establish a corepressorbased strategy for integration of inflammatory and anti-inflammatory signaling pathways, Genes and Development 23 (6) (2009) 681-693.
51. S. Ogawa, et al., A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation, Proceedings of the National Academy of Sciences of the United States of America 101 (40) (2004) 14461-14466.
52. K. Jepsen, et al., Combinatorial roles of the nuclear receptor corepressor in transcription and development, Cell 102 (6) (2000) 753-763.
53. G. Liao, et al., Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT, Journal of Biological Chemistry 278 (7) (2003) 5052-5061.
54. M.C. Hodgson, et al., The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists, Journal of Biological Chemistry 280 (8) (2005) 6511-6519.
55. M.E. Kaighn, et al., Establishment and characterization of a human prostatic carcinoma cell line (PC-3), Investigative Urology 17 (1) (1979) 16-23.
56. M.J. Campbell, et al., The anti-proliferative effects of 1alpha, 25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression, Oncogene 19 (44) (2000) 5091-5097.
57. M. Malinen, et al., Cyclical regulation of the insulin-like growth factor binding protein 3 gene in response to 1alpha, 25-dihydroxyvitamin D3, Nucleic Acids Research 39 (2) (2011) 502-512.
58. A. Saramaki, et al., Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha, 25-dihydroxyvitamin D3, Journal of Biological Chemistry 284 (12) (2009) 8073-8082.
59. K. Colston, M.J. Colston, D. Feldman, 1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture, Endocrinology 108 (3) (1981) 1083-1086.
60. C. Miyaura, et al., 1 Alpha, 25-dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells, Biochemical and Biophysical Research Communications 102 (3) (1981) 937-943.
61. E. Abe, et al., Differentiation of mouse myeloid leukemia cells induced by 1 alpha, 25-dihydroxyvitamin D3, Proceedings of the National Academy of Sciences of the United States of America 78 (8) (1981) 4990-4994.
62. E. Elstner, et al., Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells, Prostate 40 (3) (1999) 141-149.
63. D.M. Peehl, et al., Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells, Cancer Research 54 (3) (1994) 805-810.
64. K. Colston, et al., 1,25-Dihydroxyvitamin D3 receptors in human epithelial cancer cell lines, Cancer Research 42 (3) (1982) 856-859.
65. S.E. Blutt, et al., A calcitriol analogue EB1089, inhibits the growth of LNCaP tumors in nude mice, Cancer Research 60 (4) (2000) 779-782.
66. W. Banach-Petrosky, et al., Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1; Pten mutant mice, Clinical Cancer Research 12 (19) (2006) 5895-5901.
67. C.F. Garland, F.C. Garland, Do sunlight and vitamin D reduce the likelihood of colon cancer? International Journal of Epidemiology 9 (3) (1980) 227-231.
68. F.C. Garland, et al., Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation, Preventive Medicine 19 (6) (1990) 614-622.
69. C.J. Luscombe, et al., Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes, British Journal of Cancer 85 (10) (2001) 1504-1509.
70. E. Giovannucci, The epidemiology of vitamin D and cancer incidence and mortality: a review (United States), Cancer Causes and Control 16 (2) (2005) 83-95.
71. G.G. Schwartz, B.S. Hulka, Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis), Anticancer Research 10 (5A) (1990) 1307-1311.
72. E.M. John, et al., Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer, Cancer Research 65 (12) (2005) 5470-5479.
73. T.C. Chen, et al., Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer, Journal of Cellular Biochemistry 88 (2) (2003) 315-322.
74. J.Y. Hsu, et al., Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition, Cancer Research 61 (7) (2001) 2852-2856.
75. M.H. Ahonen, et al., Prostate cancer risk and prediagnostic serum 25- hydroxyvitamin D levels (Finland), Cancer Causes and Control 11 (9) (2000) 847-852.
76. D.G. Albertson, et al., Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene, Nature Genetics 25 (2) (2000) 144-146.
77. H.G. Palmer, et al., The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer, Nature Medicine 10 (9) (2004) 917-919.
78. Z. Zhang, et al., NCOR1 mRNA is an independent prognostic factor for breast cancer, Cancer Letters 237 (1) (2006) 123-129.
79. H.G. Yoon, J. Wong, The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor, Molecular Endocrinology 20 (5) (2006) 1048-1060.
80. H.G. Yoon, et al., N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso, Molecular Cell 12 (3) (2003) 723-734.
81. F. Mohn, D. Schubeler, Genetics and epigenetics: stability and plasticity during cellular differentiation, Trends in Genetics 25 (3) (2009) 129-136.
82. N. Fujita, et al., Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression, Journal of Biological Chemistry 278 (26) (2003) 24132-24138.
83. P.O. Esteve, et al., Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication, Genes and Development 20 (22) (2006) 3089-3103.
84. X. Cheng, R.M. Blumenthal, Coordinated chromatin control: structural and functional linkage of DNA and histone methylation, Biochemistry 49 (14) (2010) 2999-3008.
85. N. Le May, et al., NER factors are recruited to active promoters and facilitate chromatin modification for transcription in the absence of exogenous genotoxic attack, Molecular Cell 38 (1) (2010) 54-66.
86. R. Metivier, et al., Cyclical DNA methylation of a transcriptionally active promoter, Nature 452 (7183) (2008) 45-50.
87. S. Kangaspeska, et al., Transient cyclical methylation of promoter DNA, Nature 452 (7183) (2008) 112-115.
88. F. Pereira, et al., KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells, Human Molecular Genetics 20 (23) (2011) 4655-4665.